DXCM Total assets
Total assets at Dexcom fell to $6.3B in fiscal 2025, from $6.5B in 2024.
Total assets, as filed.
SOURCE: us-gaap:Assets · EDGAR CompanyFacts · CIK 1093557 · EDGAR ↗ · FY2021–FY2025 · ANNUAL
FY2025$6.3B
FY2024 $6.5B
HIGH$6.5B FY2024
LOW$4.9B FY2021
History AS FILED · DERIVATION SHOWN WHERE DERIVED
| Fiscal year | Total assets | Change |
|---|---|---|
| FY2025 | $6.3B | $-145M |
| FY2024 | $6.5B | +$220M |
| FY2023 | $6.3B | +$873M |
| FY2022 | $5.4B | +$458M |
| FY2021 | $4.9B | — |
More SAME DATA, OTHER VIEWS
Total assets across coverage → · DXCM company view →
Revenue · Net income · Operating cash flow · Free cash flow · Capital expenditure · Cash & equivalents · Shareholders' equity · Return on equity · Days sales outstanding
Not investment advice. Every figure on this page is an XBRL fact from the issuer's own SEC filings or an arithmetic over such facts with the method shown. No forecast is made; no posture is expressed.